Thrivent Financial for Lutherans Raises Holdings in Tema Oncology ETF (NASDAQ:CANC)

Thrivent Financial for Lutherans grew its holdings in Tema Oncology ETF (NASDAQ:CANC) by 29.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 517,837 shares of the company’s stock after buying an additional 118,328 shares during the quarter. Thrivent Financial for Lutherans owned about 20.31% of Tema Oncology ETF worth $13,156,000 at the end of the most recent quarter.

Tema Oncology ETF Stock Performance

NASDAQ:CANC opened at $24.95 on Friday. Tema Oncology ETF has a 1 year low of $23.97 and a 1 year high of $30.11. The stock has a fifty day moving average price of $25.25 and a two-hundred day moving average price of $26.57. The stock has a market capitalization of $63.62 million, a price-to-earnings ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.